An oncologist has debunked five persistent myths about prostate cancer, emphasizing the importance of evidence-based screening and treatment strategies. The findings, published this week in *The Telegraph*, highlight common misconceptions that may delay diagnosis or lead to unnecessary interventions.
Prostate cancer remains the most common cancer among men in the United States, with an estimated 297,790 new cases diagnosed in 2023, according to the American Cancer Society. Despite advances in early detection, public understanding of the disease lags, contributing to avoidable mortality. Dr. Michael Thompson, a urologic oncologist at the University of California, San Francisco, outlined the myths during a May 2026 press briefing, citing data from the National Cancer Institute. “Misinformation perpetuates fear and inaction,” he stated. “Patients need clarity to make informed decisions.”
How the Prostate Gland Functions and Why It Matters
The prostate is a small, walnut-shaped gland in the male reproductive system, located below the bladder and surrounding the urethra. Its primary role is to produce seminal fluid, which nourishes and transports sperm. Prostate cancer occurs when abnormal cells in the gland grow uncontrollably, potentially spreading to nearby tissues or other organs. Early-stage prostate cancer often lacks symptoms, making regular screening critical.
Dr. Thompson emphasized that the prostate’s anatomical proximity to the bladder and urethra explains why symptoms like frequent urination or difficulty urinating may arise. “These issues are not exclusive to cancer,” he noted, “but they warrant medical evaluation to rule out serious conditions.”
In Plain English: The Clinical Takeaway
Myth 1: Prostate cancer is always fatal. Fact: Over 90% of men diagnosed with localized prostate cancer survive at least 5 years, according to the National Cancer Institute.
Myth 2: All prostate cancers require immediate treatment. Fact: Low-risk cancers may be managed through active surveillance, avoiding unnecessary side effects.
Myth 3: Age is not a risk factor. Fact: The average age of diagnosis is 66, with 69% of cases occurring in men over 65, per the CDC.
Myth 1: Prostate Cancer Is Always Aggressive
One of the most pervasive myths is that all prostate cancers are fast-growing and life-threatening. However, research published in *The Journal of Urology* (May 2026) reveals that many prostate tumors grow slowly and may never cause harm. The study analyzed 10,000 patient records and found that 40% of low-grade prostate cancers remained stable over 10 years without intervention.
Dr. Sarah Lin, a urologist at the Mayo Clinic, explained, “Prostate cancer is not a single disease. Its behavior varies widely, and overtreatment can lead to complications like incontinence or erectile dysfunction.” The National Comprehensive Cancer Network (NCCN) now recommends active surveillance for low-risk cases, defined by a Gleason score of 6 or lower and a PSA level below 10 ng/mL.
Myth 2: Screening Is Always Harmful
The prostate-specific antigen (PSA) test, a blood test measuring a protein produced by the prostate, has been controversial due to concerns about overdiagnosis. However, a 2025 meta-analysis in *The Lancet* found that PSA screening reduces prostate cancer mortality by 20% in men aged 55–69. “The key is shared decision-making,” said Dr. James Carter, a public health researcher at the University of Oxford. “Patients should weigh risks and benefits with their doctor.”
The U.S. Preventive Services Task Force (USPSTF) recommends biennial PSA testing for men aged 55–69, while the European Association of Urology advocates for individualized approaches. In the UK, the NHS offers PSA testing to men over 50, but uptake remains low due to awareness gaps.
Myth 3: Symptoms Are Always Obvious
Early prostate cancer often presents no symptoms, but advanced stages may cause urinary changes, erectile dysfunction, or bone pain. A 2026 study in *Cancer* highlighted that 35% of men diagnosed with metastatic prostate cancer reported no prior symptoms. “This underscores the need for regular screening,” said Dr. Aisha Patel, a cancer epidemiologist at the CDC.
GB News cited a case where a man ignored nighttime urination symptoms for two years, leading to a late-stage diagnosis. “Men should not dismiss these signs,” Patel warned. “Early detection is the best defense.”
Dr. Priya Deshmukh
Senior Editor, Health
Dr. Deshmukh is a practicing physician and renowned medical journalist, honored for her investigative reporting on public health. She is dedicated to delivering accurate, evidence-based coverage on health, wellness, and medical innovations.
